Department of Chemistry and Biochemistry, Concordia University, Montreal, Quebec, H4B 1R6, Canada.
Macromol Rapid Commun. 2018 Dec;39(24):e1800477. doi: 10.1002/marc.201800477. Epub 2018 Oct 4.
Polylactide (PLA)-based amphiphilic block copolymers and their nanoassemblies designed with stimuli-responsive degradation (SRD) hold great potential as promising candidates for tumor-targeting drug delivery. However, most of the smart PLA-based nanoassemblies are designed to respond to a single stimulus (typically reduction or acidic pH). Herein, a new strategy is reported to synthesize PLA-based block copolymer micelles exhibiting dual SRD at dual locations (DL-DSRD). The strategy utilizes a combination of ring opening polymerization, controlled radical polymerization, and facile coupling reactions to synthesize an ABA-type PLA-based triblock copolymer with a hydrophilic polymethacrylate (A) and PLA (B) blocks. Incorporation of an acidic pH-responsive ketal linkage in the center of PLA block and reduction-responsive disulfide linkages at PLA/hydrophilic polymethacrylate blocks ensure the formation of smart nanoassemblies featured with ketal linkages in the PLA cores and disulfide linkages at core/corona interfaces, thus attaining DL-DSRD. Such dual acidic pH/reduction-responses at dual locations lead to not only shedding of coronas at interfaces but also destabilization of cores, resulting in the synergistic and accelerated release of encapsulated model drugs, compared with the single stimulus systems. These results, along with lower cytotoxicity, suggest that DL-DSRD strategy can offer versatility in the development of tumor-targeting drug delivery nanocarriers.
基于聚乳酸(PLA)的两亲嵌段共聚物及其具有刺激响应性降解(SRD)的纳米组装体作为肿瘤靶向药物输送的有前途的候选物具有很大的潜力。然而,大多数智能 PLA 基纳米组装体旨在响应单一刺激(通常是还原或酸性 pH)。在此,报道了一种新的策略,用于合成在两个位置(DL-DSRD)表现出双重 SRD 的基于 PLA 的嵌段共聚物胶束。该策略利用开环聚合、可控自由基聚合和简便的偶联反应相结合,合成了一种具有亲水性聚甲基丙烯酸酯(A)和 PLA(B)嵌段的 ABA 型 PLA 三嵌段共聚物。在 PLA 嵌段的中心引入酸性 pH 响应性缩酮键,并在 PLA/亲水性聚甲基丙烯酸酯嵌段处引入还原响应性二硫键,确保形成具有 PLA 核中缩酮键和核/冠界面中二硫键的智能纳米组装体,从而实现 DL-DSRD。这种在两个位置的双重酸性 pH/还原响应不仅导致界面处冠的脱落,而且导致核的不稳定性,从而导致封装的模型药物的协同和加速释放,与单一刺激系统相比。这些结果以及较低的细胞毒性表明,DL-DSRD 策略可为肿瘤靶向药物输送纳米载体的开发提供多功能性。